Interest in tight glycemic control in the insulin-dependent diabetic has intensified over the past decade. This was prompted by observations that such regimens may decrease the long term sequelae of diabetes. Such regimens, however, are usually associated with frequent episodes of hypoglycemia. Several studies in the literature have suggested that insulin-induced hypoglycemia is associated with enhanced glucose production, ketogenesis and lipolysis. Recent observations in the investigators laboratory have also indicated that hypoglycemia, secondary to insulin use, is also associated with enhanced total body proteolysis. The studies further showed that most of this response was secondary to enhanced proteolysis by the extra-hepatic splanchnic tissues (the gut). The mechanism of such changes in total body and regional proteolytic rates remains obscure and will be the subject of the investigator's revised proposal. Additional studies from the investigator's laboratory have also shown that the maintenance of relative """"""""central glycemia"""""""", using selective infusions of glucose into both carotid and vertebral arteries, while peripheral hypoglycemia was maintained (= 43 mg/dl) completely) completely abolished this excessive proteolytic response. Relative """"""""central glycemia"""""""" blunted but did not abolish the response in plasma catecholamines. In attempt to establish whether the observed rises in plasma glucagon, cortisol, and catecholamines played a role in the proteolytic response, the investigators infused these hormones intravenously, either singly or in combination, with and without insulin, at rates intended to achieve plasma levels comparable to those seen with insulin induced hypoglycemia. Changes in amino acid fluxes were estimated using established isotopic methods in combination with regional balance techniques. The investigator's data indicate that in none of these studies, however, did the investigators observe any increase in the rates of proteolysis. Only central (intracerebroventricular) administration of beta-endorphin resulted in marked stimulation of the proteolytic responses. These data suggest that the majority of the proteolytic responses with insulin-induced hypoglycemia are most likely centrally mediated, and are triggered by """"""""central glucopenia"""""""" which in turn activates the central endorphinergic system. The present proposal will examine these mechanisms in more detail and will attempt to determine the role that the central endorphinergic system plays in eliciting this proteolytic response.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK042562-04
Application #
3243697
Study Section
Metabolism Study Section (MET)
Project Start
1992-01-01
Project End
1996-06-30
Budget Start
1993-09-30
Budget End
1994-06-30
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
State University New York Stony Brook
Department
Type
Schools of Medicine
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Cersosimo, E; Molina, P E; Abumrad, N N (1998) Renal lactate metabolism and gluconeogenesis during insulin-induced hypoglycemia. Diabetes 47:1101-6
Cersosimo, E; Molina, P E; Abumrad, N N (1997) Renal glucose production during insulin-induced hypoglycemia. Diabetes 46:643-6
Cersosimo, E; Ajmal, M; Naukam, R J et al. (1997) Role of the kidney in plasma glucose regulation during hyperglycemia. Am J Physiol 272:E756-61
Molina, P E; Williams, P; Abumrad, N N (1997) Histaminergic contribution to the metabolic effects of neuroglucopenia. Am J Physiol 272:R1918-24
Bundz, S; Molina, P E; Lang, C H et al. (1995) Endogenous opiates do not modulate LPS-induced alterations in carbohydrate metabolism. Shock 4:397-402
Molina, P E; Jabbour, K; Williams, P et al. (1994) Effect of acute ethanol intoxication on glucoregulation during prolonged insulin-induced hypoglycemia. Am J Physiol 267:R1280-7
Flakoll, P J; Borel, M J; Wentzel, L S et al. (1994) The role of glucagon in the control of protein and amino acid metabolism in vivo. Metabolism 43:1509-16
Yousef, K A; Tepper, P G; Molina, P E et al. (1994) Differential control of glucoregulatory hormone response and glucose metabolism by NMDA and kainate. Brain Res 634:131-40
Petit, F; Jarrous, A; Dickinson, R D et al. (1994) Contribution of central and peripheral adrenergic stimulation to IL-1 alpha-mediated glucoregulation. Am J Physiol 267:E49-56
Molina, P E; Tepper, P G; Yousef, K A et al. (1994) Central NMDA enhances hepatic glucose output and non-insulin-mediated glucose uptake by a nonadrenergic mechanism. Brain Res 634:41-8

Showing the most recent 10 out of 14 publications